Connection
Srinivasa Govindarajan to Treatment Outcome
This is a "connection" page, showing publications Srinivasa Govindarajan has written about Treatment Outcome.
|
|
Connection Strength |
|
|
|
|
|
0.026 |
|
|
|
-
Sinha A, Mathew G, Arushi A, Govindarajan S, Ghanapriya K, Grewal N, Rai K, Brijwal M, Kalluru SL, Tewari P, Misra A, Khandelwal P, Hari P, Bagga A. Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects. Nephrol Dial Transplant. 2023 03 31; 38(4):939-949.
Score: 0.026